Details for New Drug Application (NDA): 218426
✉ Email this page to a colleague
The generic ingredient in DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE is dextromethorphan hydrobromide; quinidine sulfate. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; quinidine sulfate profile page.
Summary for 218426
| Tradename: | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE |
| Applicant: | Hetero Labs Ltd Iii |
| Ingredient: | dextromethorphan hydrobromide; quinidine sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 218426
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | dextromethorphan hydrobromide; quinidine sulfate | CAPSULE;ORAL | 218426 | ANDA | Camber Pharmaceuticals, Inc. | 31722-693 | 31722-693-60 | 60 CAPSULE in 1 BOTTLE (31722-693-60) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 20MG;10MG | ||||
| Approval Date: | Aug 28, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
